Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | REN | P00797 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5458039 | 0.95 | L3MBTL1 (0.44) | L3MBTL1LMNAMAPTTP53TSHR | |
| SCHEMBL5467951 | 0.93 | EPHX2 (0.38) | L3MBTL1ALOX5EPHX2LMNAEPHX1 | |
| SCHEMBL5461306 | 0.92 | EPHX2 (0.37) | L3MBTL1ALOX5EPHX2MAPTEPHX1 | |
| SCHEMBL5457958 | 0.91 | EPHX2 (0.38) | L3MBTL1ALOX5EPHX2EPHX1 | |
| SCHEMBL5456461 | 0.89 | L3MBTL1 (0.45) | L3MBTL1EPHX2LMNAMAPTTP53 | |
| SCHEMBL5455660 | 0.88 | L3MBTL1 (0.39) | L3MBTL1EPHX2LMNAMAPTEPHX1 | |
| SCHEMBL5324822 | 0.88 | L3MBTL1 (0.41) | L3MBTL1EPHX2LMNATP53TSHR | |
| SCHEMBL5452080 | 0.86 | L3MBTL1 (0.39) | L3MBTL1EPHX2 | |
| SCHEMBL5329757 | 0.83 | ALOX5 (0.47) | L3MBTL1ALOX5LMNAPOLBALDH1A1 | |
| SCHEMBL5458827 | 0.82 | L3MBTL1 (0.39) | L3MBTL1EPHX2LMNAMAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070281996-A1 | Creatine prodrugs, compositions and uses thereof | XENOPORT, INC. | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281996-A1 | Creatine prodrugs, compositions and uses thereof | CKMT1A; CKMT1B, PYGM, TNNI3 | L3MBTL1 2963/4885ALOX5 3349/4885EPHX2 2614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.